Panelists: Health Technology Assessments - A New Reality for Innovation only?
Urs Brügger is a health economist and director of the Winterthur Institute of Health Economics (WIG) at the Zurich University of Applied Sciences (ZHAW) in Winterthur, Switzerland. His fields of interest in research and teaching are health technology assessment (HTA), economic evaluations and reimbursement systems.
He is a board member of the Swiss Academy of Medical Sciences (SAMS) and the Spital Thurgau AG. He studied economics and sociology at the University of St Gallen (HSG), and in 2009 obtained an MSc in HTA (Ulysses programme).
Over the last 25 years Beat has held a number of leadership roles in logistics, quality assurance, business consulting and finance. Before he joined Zimmer Biomet, he worked for Ernst & Young, heading the financial advisory department for public services in Switzerland.
He represents the interests of the Swiss medtech industry in working groups of FASMED, MedtechEurope, economiesuisse, and sits on the Business and Industry Advisory Committee to the OECD and the Advisory Committee for General Benefits and Questions of Principle (ELGK).
Markus Gnägi has been working at santésuisse since 2006, where he performs a variety of functions. He is responsible for the List of Medical Supplies and Devices and heads the department responsible for official tariffs and of the department Grundlagen a.i.
Simon Hoelzer was involved in research and teaching at the University of Giessen, Germany. Between 2002 and 2008, he worked for H+. In his capacity as deputy managing director of H+, he represented the Swiss hospitals at a national level. He has been responsible for directing and executing a substantial number of eHealth and public health projects, many of which were implemented in the field with the close involvement of national senior policy makers. Since 2005, Simon Hoelzer has served as chairman of the SGfM. In 2007, he was appointed managing director of SwissDRG AG (Inc.), a non-profit organisation with the cantons, insurers, hospitals and medical professionals of Switzerland as its shareholders.
Markus is Global Head of Market Access, Policy & Pricing, managing governmental relationships at Ascensia Diabetes Care (part of Panasonic Holding), based in Switzerland.
He is a member of the global management team (eALT) at the company and sits on the Executive Board of EDMA/MedTech Europe, representing the Swiss Diagnostic Association (SVDI) where he also sits on the Executive Board.
Stefan Otto has been co-director of the Medical Services Division in the Department of Health and Accident Insurance at the Federal Office of Public Health (FOPH) since 2013.Following his medical studies at the University of Bern and five years as an assistant physician, Stefan Otto switched to a career in administration in 1996.
He first worked in the Solothurn health department, then in the health insurance department of the then Federal Social Insurance Office. In 2002 he took over in the Medical Directorate at the Inselspital, Bern. He then worked as a freelance consultant before taking up his position at the FOPH in 2013.
Henrik Pfahler is the Head of Medical Controlling, Quality and Safety Management and Innovation Management at Insel Gruppe AG, Bern. He is also responsible for various strategical projects such as mergers, OR management and standardisation of the health IT environment. As an expert in the Swiss health care system over the last twelve years, during this time he has sat on several committees and advisory boards for the public and private sector.
Henrik is doctor of medicine and obtained an Executive Master of Business Administration degree from the University of St Gallen.
Hansjörg Riedwyl is a founding member and CEO of ISS AG Integrated Scientific Services and co-founder of several medtech companies.
Hansjörg Riedwyl is specialised in service management and regulatory strategies and regulatory intelligence from both an operative and organisational perspective.
Fabian Stadler is Strategic Account Manager at Johnson & Johnson Medical Devices Companies Switzerland. He lectures in business ethics, acts as an arbitrator for social security litigation and is a member of national and international medtech expert groups.
He obtained a law degree from the University of Fribourg in 2005, specialising in European law, and was admitted to the Swiss bar association. As attorney-at-law he was partner in a law Firm in Bern, Secretary-General of the Swiss medtech association FASMED and Legal Counsel of several enterprises, corporations, foundations and associations.
Dominik Straumann has been senior market access and reimbursement manager at B. Braun Medical AG since November 2016. In his previous role, which he held from 2011, he was a health economics project manager.
Prior to that he was an associate manager at Zimmer GmbH in the field of health economics and reimbursement EMEA and an international health economics specialist. Between 2001 and 2006 he was a manager at the Medical Learning Centre at the University of Basel.
Gabor Szekely is member of CTI since 2010 and responsible for MedTech since 2013. He is Professor for Medical Image Analysis and Visualization at ETH Zurich, heading the research group Medical Image Computing at the Computer Vision Laboratory.
Between 2001 and 2013 he was Director of the National Center of Competence in Research on Computer Aided and Image Guided Medical Interventions (NCCR Co-Me).
Markus Trutmann MD has been secretary general of the fmCh since 2006, where his main interests lie in health policy, health economics, quality assurance and HTA. From 2005 to 2006, he worked at the Swiss Conference of the Cantonal Ministers of Public Health (GDK), where he was in charge of the primary care medicine and highly specialized medicine dossiers. Between 1997 and 2005, Markus Trutmann worked as an editor-in-chief of Schweizerische Ärzteteitung and an editor of the Gesundheitsökonomie book series at Swiss Medical Publishers EMH. From 1989 to 1997, Trutmann worked as an assistant doctor and chief consultant in general surgery at Rheinfelden, Basel, in the Principality of Monaco and Olten.
Graduation at the federal university of technology in electrical engineering. More than 20 years in the MedTech industry, covering national and international positions in clinical support, sales, marketing and education.
Since 2012 focus on Reimbursement and Health Care Economics. Member of the trade commission of FASMED , leading its tariff working group.
Barbara Züst has been director of the Swiss Patient Organisation (SPO) since 2016. From 2008 to 2015, after doing an internship at the district court in Frauenfeld (2005-2007), she worked as an adviser and co-managing director at the SPO. After completing her Master of Law at the University of St Gallen (2005), Züst worked as a licensed nurse AKP in Zurich and later as an nurse anaesthesist at the St Gallen cantonal hospital. Barbara Züst was a member of the Ethics Committee of the Canton of Zurich (KEK) from 2012 to 2015,and has sat on the Federal Medical Services Commission (FMSC) since 2014 and on the Quality Assurance Commission of the Swiss Society for Gynaecology and Obstetrics (SGGG) since 2013.